HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holmes, M. A. Articles by Foote, J. Search for Related Content PubMed PubMed Citation Articles by Holmes, M. A. Articles by Foote, J.

Structural Effects of Framework Mutations on a Humanized Anti-Lysozyme Antibody¹

Margaret A. Holmes^*, Timothy N. Buss^* and Jefferson Foote^2,*,

^* Program in Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and Department of Immunology, University of Washington, Seattle, WA 98195

A humanized version of the mouse anti-lysozyme Ab D1.3 was previously constructed as an Fv fragment and its structure was crystallographically determined in the free form and in complex with lysozyme. Here we report five new crystal structures of single-amino acid substitution mutants of the humanized Fv fragment, four of which were determined as Fv-lysozyme complexes. The crystals were isomorphous with the parent forms, and were refined to free R values of 28–31% at resolutions of 2.7–2.9 Å. Residue 27 in other Abs has been implicated in stabilizing the conformation of the first complementarity-determining region (CDR) of the H chain, residues 31–35. We find that a Phe-to-Ser mutation at 27 alters the conformation of immediately adjacent residues, but this change is only weakly transmitted to Ag binding residues in the nearby CDR. Residue 71 of the H chain has been proposed to control the relative disposition of H chain CDRs 1 and 2, based on the bulk of its side chain. However, in structures we determined with Val, Ala, or Arg substituted in place of Lys at position 71, no significant change in the conformation of CDRs 1 and 2 was observed.

This article has been cited by other articles:

				A. K. Kashyap, J. Steel, A. F. Oner, M. A. Dillon, R. E. Swale, K. M. Wall, K. J. Perry, A. Faynboym, M. Ilhan, M. Horowitz, et al. From the Cover: Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies PNAS, April 22, 2008; 105(16): 5986 - 5991. [Abstract] [Full Text] [PDF]

				T. Nakanishi, K. Tsumoto, A. Yokota, H. Kondo, and I. Kumagai Critical contribution of VH-VL interaction to reshaping of an antibody: The case of humanization of anti-lysozyme antibody, HyHEL-10 Protein Sci., February 1, 2008; 17(2): 261 - 270. [Abstract] [Full Text] [PDF]

				K. Makabe, T. Nakanishi, K. Tsumoto, Y. Tanaka, H. Kondo, M. Umetsu, Y. Sone, R. Asano, and I. Kumagai Thermodynamic Consequences of Mutations in Vernier Zone Residues of a Humanized Anti-human Epidermal Growth Factor Receptor Murine Antibody, 528 J. Biol. Chem., January 11, 2008; 283(2): 1156 - 1166. [Abstract] [Full Text] [PDF]

				P. Tan, D. A. Mitchell, T. N. Buss, M. A. Holmes, C. Anasetti, and J. Foote "Superhumanized" Antibodies: Reduction of Immunogenic Potential by Complementarity-Determining Region Grafting with Human Germline Sequences: Application to an Anti-CD28 J. Immunol., July 15, 2002; 169(2): 1119 - 1125. [Abstract] [Full Text] [PDF]